Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 6/20 | 0.42 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.41 |
| ▸ | HTR3B | O95264 | 1/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.41 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.41 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.41 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.41 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL63468 | 0.76 | ALDH1A1 (0.67) | ALDH1A1TSHRKIF11HTR3EHTR3B | |
| SCHEMBL432591 | 0.74 | CES2 (0.41) | ALDH1A1TSHRCES2 | |
| SCHEMBL663624 | 0.74 | TSHR (0.48) | ALDH1A1TSHRKIF11 | |
| SCHEMBL3126195 | 0.74 | ALDH1A1 (0.43) | ALDH1A1TSHRKIF11CES2CES1 | |
| SCHEMBL16626100 | 0.74 | ALDH1A1 (0.56) | ALDH1A1TSHRKIF11HTR3EHTR3B | |
| Bromide SCHEMBL2959626 | 0.72 | TSHR (0.46) | ALDH1A1TSHRKIF11 | |
| SCHEMBL538930 | 0.72 | TSHR (0.48) | ALDH1A1TSHRHTR3EHTR3BHTR3A | |
| SCHEMBL11239014 | 0.71 | ALDH1A1 (0.53) | ALDH1A1TSHRKIF11HTR3EHTR3B | |
| SCHEMBL677817 | 0.71 | ALDH1A1 (0.53) | ALDH1A1TSHRKIF11CES2CES1 | |
| SCHEMBL13205250 | 0.71 | ALDH1A1 (0.53) | ALDH1A1TSHRKIF11HTR3EHTR3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118908996-A | A composition containing C (sp2) P bond or C (sp)3) Process for preparing organic phosphine compound of-P bond | 烟台大学 | 2024-11-08 | — | — | CN | claimed |
| EP-0023093-B1 | PENICILLANIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS WITH A PENICILLIN OR CEPHALOSPORIN | BEECHAM GROUP PLC (GB) | 1983-09-28 | — | — | EP | claimed |
| US-20260132109-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2026-05-14 | — | — | US | disclosed |
| US-20260022130-A1 | HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2026-01-22 | — | — | US | disclosed |
| US-20260008764-A1 | BACKBONE CLEAVABLE POLYMETHACRYLATES VIA THIONOLACTONE COMONOEMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-01-08 | — | — | US | disclosed |
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | NOVARTIS PHARMA AG (CH) | 2025-12-23 | — | — | US | disclosed |
| EP-4587424-A1 | YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS | Bridgene Biosciences, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025038673-A9 | BACKBONE CLEAVABLE POLYMETHACRYLATES VIA THIONOLACTONE COMONOEMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-05-22 | — | — | WO | disclosed |
| CN-116410088-B | Synthesis method of alpha-aryl propionate compound | 南京工业大学 | 2025-05-02 | — | — | CN | disclosed |
| CN-119894866-A | YAP/TAZ-TEAD oncoprotein inhibitors | 布里奇恩生物科学公司 | 2025-04-25 | — | — | CN | disclosed |
| US-12281124-B2 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-4456761-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1984-06-26 | — | — | US | disclosed |
| US-4387230-A | Process for preparing a dihydropyridine derivative | JOHN WYETH AND BROTHER LIMITED (GB) | 1983-06-07 | — | — | US | disclosed |
| US-4356182-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1982-10-26 | — | — | US | disclosed |
| US-4291040-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1981-09-22 | — | — | US | disclosed |
| US-4265907-A | Insecticidal hydroxylamine ethers | MOBIL OIL CORPORATION (US) | 1981-05-05 | — | — | US | disclosed |
| US-4221744-A | Hydroformylation process employing rhodium-based catalysts comprising ligands having electronegative substituents | CELANESE CORPORATION (US) | 1980-09-09 | — | — | US | disclosed |
| US-4152344-A | CATALYSTS FOR HYDROFORMYLATION OF ALPHA-OLEFINS | CELANESE CORPORATION (US) | 1979-05-01 | — | — | US | disclosed |
| US-4105849-A | [(Substituted )phenyl]phenylmethyl-1-(dialkylaminoalkyl)piperidines | G. D. SEARLE & CO. (US) | 1978-08-08 | — | — | US | disclosed |
| US-3959475-A | ANTIDEPRESSANT, TRANQUILIZER, ANALGESIC | AMERICAN HOECHST CORPORATION (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022130-A1 | HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | LIPC, LIPA, LPL | ALDH1A1 1338/4885TSHR 1083/4885KIF11 3182/4885 |
| US-20260132109-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | STING1, IRF3, CGAS | ALDH1A1 3829/4885TSHR 3744/4885KIF11 4488/4885 |
| US-12281124-B2 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | LIPC, LPL, MGLL | ALDH1A1 525/4885TSHR 1624/4885KIF11 3953/4885 |
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | STING1, CGAS, IRF3 | ALDH1A1 4654/4885TSHR 4487/4885KIF11 4125/4885 |
| US-20260008764-A1 | BACKBONE CLEAVABLE POLYMETHACRYLATES VIA THIONOLACTONE COMONOEMERS | MSRB3, SCN2B, MMAB | ALDH1A1 2501/4885TSHR 441/4885KIF11 3428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.